Arcadia Biosciences Inc expected to post a loss of 30  cents a share - Earnings Preview

Arcadia Biosciences

10/08/2022 03:04

* Arcadia Biosciences Inc  RKDA.OQ   RKDA.O  is expected
to show a
rise in quarterly revenue when it reports  results on August
11. 
    * The Davis California-based  company is expected to report 
a
62.9% increase in revenue to $2.289 million from $1.41 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Arcadia Biosciences
Inc
is for a loss of 30 cents per share. For the same quarter last
year, the company reported a loss of 24 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $3.75​, above​ its last closing price
of $0.92. ​​​

This summary was machine generated August 10 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated